Received May 14, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Z006283 | — |
No additional AE/PQC; Inbound call from HCP who stated that MMR-II was administered after a TE excursion. Additional AE reported under 02998605. Consent for follow up was provided. No additional AE/PQC. Names of vaccines involved (including lot/exp): MMR-2| Lot: z006; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drugs reactions or allergies were not reported. On 05-May-2026, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), lot #Z006283 has been verified to be a valid lot number, expiration date: 19-Mar-2027, administered for prophylaxis (dose, route of administration and anatomical site of injection were not provided). Reconstituted with sterile diluent (BAXTER Sterile Diluent), (indication, expiration date, and lot # were not reported). The vaccine was administered after a temperature excursion in which it was exposed to 65°F for 6 hours (Product storage issue). No previous temperature excursions or additional adverse events were reported (no adverse event).
Sterile diluent